BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Deals

Inspire, Merck deal

Merck will acquire ophthalmic company Inspire for $5 per share, or about $430 million in cash. The price is a 26% premium to Inspire's close of $3.98 on April 4, the day before the deal was announced. The boards of both companies have approved the deal. Merck said Inspire's commercialization organization will...

Read the full 240 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >